41 – 50 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study.
(
- Contribution to journal › Article
-
Mark
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
(
- Contribution to journal › Article
- 2013
-
Mark
Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
(
- Contribution to journal › Article
-
Mark
Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Non-Lymphoma Hematological Malignancies in Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Cancer risk in systemic lupus: An updated international multi-centre cohort study
(
- Contribution to journal › Article
-
Mark
Headache in Systemic Lupus Erythematosus Results From a Prospective, International Inception Cohort Study
(
- Contribution to journal › Article
- 2012
-
Mark
Combination of Autoantibodies Against Different Histone Proteins Influences Complement-dependent Phagocytosis of Necrotic Cell Material by Polymorphonuclear Leukocytes in Systemic Lupus Erythematosus.
(
- Contribution to journal › Article
-
Mark
Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
(
- Contribution to journal › Article